1998

Adelman, AG, Caramori, PR, Cohen, EA, Chisholm, RJ, Cote, G, Ducas, J, O'Neill, BJ, and Tcheng, JE (1998).
The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era
.

Alexander, JH and Harrington, RA (1998).
Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT
.

Alexander, JH, Alexander, K, Kong, DF, Tung, CY, and Whellan, D (1998).
Session highlights from the American Heart Association Scientific Sessions: November 9-12, 1997
.

Alexander, JH, Greenbaum, AB, Hudson, MP, Kong, DF, Miller, JM, Tung, CY, and Whellan, DJ (1998).
Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998
.

Alexander, JH, Greenbaum, AB, Hudson, MP, Kong, DF, Miller, JM, Tung, CY, and Whellan, DJ (1998).
Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998
.

Alexander, KP, Peterson, ED, Granger, CB, Casas, AC, Van, de, Armstrong, PW, Guerci, A, Topol, EJ, and Califf, RM (1998).
Potential impact of evidence-based medicine in acute coronary syndromes insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial
.

Alexander, KP, Shaw, LJ, Shaw, LK, DeLong, ER, Mark, DB, and Peterson, ED (1998).
Value of exercise treadmill testing in women
.

Alspaugh, JA, Perfect, JR, and Heitman, J (1998).
Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans
.

Anderson, RD, Ohman, EM, Holmes, DR, Harrington, RA, Barsness, GW, Wildermann, NM, Phillips, HR, Topol, EJ, and Califf, RM (1998).
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions
.

Angold, A, Messer, SC, Stangl, D, Farmer, EM, Costello, EJ, and Burns, BJ (1998).
Perceived parental burden and service use for child and adolescent psychiatric disorders
.

Ardissino, D, Merlini, PA, Eisenberg, P, Kottke-Marchant, K, Crenshaw, BS, and Granger, CB (1998).
Coagulation markers and outcomes in acute coronary syndromes
.

Armstrong, PW, Fu, Y, Chang, WC, Topol, EJ, Granger, CB, Betriu, A, Van, de, Lee, KL, and Califf, RM (1998).
Acute coronary syndromes in the GUSTO-IIb trial prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators
.

Bastian, LA, Nanda, K, Hasselblad, V, and Simel, DL (1998).
Diagnostic efficiency of home pregnancy test kits. A meta- analysis
.

Batchelor, WB, Robinson, R, and Strauss, BH (1998).
The extracellular matrix in balloon arterial injury: a novel target for restenosis prevention
.

Bates, ER, Stomel, RJ, Hochman, JS, and Ohman, EM (1998).
The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock
.

Beckham, JC, Moore, SD, Feldman, ME, Hertzberg, MA, Kirby, AC, and Fairbank, JA (1998).
Health status, somatization, and severity of posttraumatic stress disorder in Vietnam combat veterans with posttraumatic stress disorder
.

Bengur, AR, Li, JS, Herlong, JR, Jaggers, J, Sanders, SP, and Ungerleider, RM (1998).
Intraoperative transesophageal echocardiography in congenital heart disease
.

Berkowitz, SD, Frelinger, AL, and Hillman, RS (1998).
Progress in point-of-care laboratory testing for assessing platelet function.
.

Berkowitz, SD, Sane, DC, Sigmon, KN, Shavender, JH, Harrington, RA, Tcheng, JE, Topol, EJ, and Califf, RM (1998).
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group
.

Betriu, A, Califf, RM, Bosch, X, Guerci, A, Stebbins, AL, Barbagelata, NA, Aylward, PE, Vahanian, A, Van, de, and Topol, EJ (1998).
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries
.

Bhatt, DL, Lincoff, AM, Kereiakes, DJ, Tcheng, JE, Simoons, ML, Vanderwieken, LR, Godfrey, N, Califf, RM, and Topol, EJ (1998).
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention
.

Blankenship, JC, Hellkamp, AS, Aguirre, FV, Demko, SL, Topol, EJ, and Califf, RM (1998).
Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial
.

Block, PC, Peterson, EC, Krone, R, Kesler, K, Hannan, E, O'Connor, GT, and Detre, K (1998).
Identification of variables needed to risk adjust outcomes of coronary interventions - evidence-based guidelines for efficient data collection
.

Braunwald, E, Maseri, A, Armstrong, PW, Califf, RM, Gibler, WB, Hamm, CW, Simoons, ML, and Van, de (1998).
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes
.

Braunwald, E, Maseri, A, Armstrong, PW, Califf, RM, Gibler, WB, Hamm, CW, Simoons, ML, and Van, de (1998).
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes
.